Advanced search
Publication Cover
Cancer Investigation Volume 6, 1988 - Issue 1
Submit an article Journal homepage
23
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Cisplatin and Etoposide as Second-Line Chemotherapy in Patients with Small Cell Lung Cancer

Franco Figoli Division of Medical Oncology, Centro dl Riferimento Oncologico, Aviano
,
Andrea Veronesi Division of Medical Oncology, Centro dl Riferimento Oncologico, Aviano
,
Andrea Ardizzoni Division of Medical Oncology, Centro dl Riferimento Oncologico, Aviano
,
Luciano Canobbio Division of Medical Oncology, Tumor Institute, Geneva
,
Gioia Bruschi Division of Medical Oncology, Centro dl Riferimento Oncologico, Aviano
,
Francesco Mazza Division of Pneumology, General Hospital, Pordenone, Italy
,
Vittorina Zagonel Division of Medical Oncology, Centro dl Riferimento Oncologico, Aviano
,
Giovanni Lo Re Division of Medical Oncology, Centro dl Riferimento Oncologico, Aviano
,
Riccardo Rosso Division of Medical Oncology, Centro dl Riferimento Oncologico, Aviano
&
Silvio Monfardini Division of Medical Oncology, Centro dl Riferimento Oncologico, Aviano
 show all
Pages 1-5 | Published online: 11 Jun 2009

References

  • Arnold A M, Whitehouse J MA. Etoposide: a new anti-cancer agent. Lancet 1981; 2: 1
  • Cavalli F, Sonntag R W, Jung F, et al. VP16-213 monotherapy for remission induction of small cell lung cancer, A randomized trial using three dosage schedules. Cancer Chemother Rep 1978; 62: 473
  • Tucker R D, Ferguson A, Van Wick C, et al. Chemotherapy of small cell carcinoma of the lung with VP-16-213. Cancer 1978; 41: 1710
  • Asbury R A, Rubins J, Bennett J M. Etoposide in small lung cancer resistant to prior chemotherapy. Cancer Treat Rep 1983; 67: 951
  • Issel B F, Einhorn L H, Comis R L, et al. Multicenter phase II trial of Etoposide in refractory small cell lung cancer. Cancer Treat Rep 1985; 69: 1
  • Dombernowsky P, Soreson S, Aisher J. Cis Dichlorodiammineplatinum in small cell anaplastic bronchogenic carcinoma: a phase II study. Cancer Treat Rep 1979; 63: 543
  • Levenson R M, Ihde D, Hubermann M S, et al. Phase II trial of cisplatin in small cell carcinoma of the lung. Cancer Treat Rep 1985; 65: 1
  • Mabel J A. Therapeutic synergism in murine tumors for combination of cis-diamminedichloroplatinum with VP16-213 or BCNU. Proc Am Assoc Cancer Res and ASCO 1979; 20: 230
  • Osoba D, Evans W K, Feld R. VP-16 and cis-platinum (P) combination chemotherapy for relapse in small cell lung cancer (SCLC). Proc Am Assoc Cancer Res and ASCO 1981; 22: 495
  • Porter L L, Johnson D H, Hainsworth J D, et al. Cisplatin and etoposide combination chemotherapy for refractory small cell carcinoma of the lung. Cancer Treat Rep 1985; 69: 479
  • Sierocki J S, Hilaris B S, Hopfan S, et al. Cis- dichlorodiammineplatinum (II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung. Cancer Treat Rep 1979; 63: 1593
  • Tinsley R, Comis R, DiFino S, et al. Potential clinical synergy observed in the treatment of small cell lung cancer (SCLC) with cisplatin (P) and VP-16-213 (V). Proc ASCO 1983; 24: 1
  • Miller A, Hoogstraten B. B, Staquet M, Wilkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207
  • Cohen M N, Broder L E, Fossieck B E. Phase II clinical trial of weekly administraton of VP16-213 in small cell bronchogenic carcinoma. Cancer Treat Rep 1977; 61: 489
  • Evans W K, Feld R, Osoba D, et al. VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer. Cancer 1984; 53: 1461
  • Evans W K, Osoba D, Feld R, et al. Etoposide (VP16) and eisplatin: an effective treatment for relapse in small-cell lung cancer. J Clin Oncol 1985; 3: 65
  • Lopez J, Mann A. J, Grapski R T, et al. Etoposide and cisplatin selvage chemotherapy for small cell lung cancer. Cancer Treat Rep 1985; 69: 1
  • Madrigal P A, Manga G P, Palamiro A. VP-16 combined with cisplatinum in the treatment of SCLC. Cancer Chemother Pharmacol 1982; 7: 203
  • Minna J D, Higginns G A, Glatstein E J. Cancer of the lung. Cancer Principles and Practice of Oncology. JB Lippincott Company, Philadelphia Toronto 1982; 450

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.